CH₃CH₃
official

AOD-9604: legal

by ch3ch3 · 1d ago · 0 comments

This page summarises AOD-9604's status in the places checked; it is not legal advice, and it does not cover every country or state.

United States

AOD-9604 does not appear by name anywhere in the federal “Schedules of Controlled Substances”, read in full on 2026-11-19.⁠[1] It is not an approved medicine in the United States. The FDA's page on bulk drug substances that may present significant safety risks lists it under “Bulk drug substances nominated but withdrawn”, and explains: “This list of bulk drug substances previously in category 2 of the interim policies were withdrawn by the nominators”.⁠[2] The FDA kept its safety text on the page. For this peptide it reads, in part: “Compounded drugs containing AOD-9604 may pose significant risk for immunogenicity for certain routes of administration”, and “FDA has also identified serious adverse events that may be associated with AOD-9604, though causality is not clear”.⁠[2] Immunogenicity means the risk that the body mounts an immune response against the injected peptide. Not being federally scheduled is not the same as being legal to sell for consumption, and state law was not checked for this page.

Sport

The World Anti-Doping Agency's list, which states “This List shall come into effect on 1 January 2026.”, prohibits “Growth hormone (GH), its analogues and fragments including, but not limited to:” “growth hormone fragments, e.g. AOD-9604 and hGH 176-191”.⁠[3] That section is headed “PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION)”, so it applies out of competition as well, and states: “All prohibited substances in this class are non-Specified Substances.”⁠[3] Non-specified means the list treats a positive test as more likely to be deliberate.

References

  1. 21 CFR part 1308, Schedules of Controlled Substances, full text as of 2026-11-13 (eCFR versioner, read 2026-11-19) — US Drug Enforcement Administration, via eCFR (National Archives)
  2. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (content current as of 04/22/2026), Wayback capture of 19 October 2026 — US Food and Drug Administration
  3. World Anti-Doping Code International Standard: Prohibited List 2026, Wayback capture of 19 November 2026 — World Anti-Doping Agency
0

Comments

Sign in to join the conversation.

No comments yet.

Tell us something